UK Life Sciences Company Directory

Selective breeding of Black Soldier Fly for insect farming

Beta Bugs is an insect genetics company that develops and supplies genetically selected Black Soldier Fly breeds to insect farmers. Using multi-trait selective breeding and genomic selection tools developed in collaboration with the Roslin Institute, the company produces improved strains designed to increase larval…

Phage-based blood test for tuberculosis and mycobacterial disease

PBD Biotech is a diagnostics company that develops phage-based blood and milk tests for detecting active mycobacterial infections, including bovine tuberculosis, Johne's disease and human tuberculosis. Its proprietary technology uses bacteriophages to selectively infect live mycobacteria, enabling rapid, accurate…

ENTECH platform for cell perturbation and AI target discovery

Aparna Bio develops technologies for generating biologically relevant cell-perturbation data to support drug target discovery. Its ENTECH platform is being engineered to deliver experimental perturbation reagents into primary human cells and other disease-relevant models, where conventional delivery methods can be…

Dark genome platform identifying first-in-class targets for autoimmune disease

Nucleome Therapeutics is a drug discovery company using 3D genome mapping to identify therapeutic targets encoded in the non-coding regions of the human genome. Its platform integrates high-resolution chromatin conformation data with functional genomics and machine learning to link disease-associated genetic variants…

Integrated electronic lab notebooks and molecular biology software

Lab Thread is a laboratory software company developing an integrated platform for biological research teams. Its system combines electronic laboratory notebooks, sample and inventory tracking, molecular biology design tools, and project management. Researchers can connect DNA sequence work, experimental protocols,…

Blue-mussel-derived bioactive peptide therapy for veterinary research

N2 Pharmaceuticals develops N2-01, an injectable mixture of bioactive peptides and amino acids derived from blue mussels. Its research focuses on endothelial dysfunction and vascular permeability, with potential applications in veterinary medicine and human disease. The company reports historic veterinary use in…

Bioinformatics data platform for biology teams at scale

Goodwright is a London-based software company developing Flow, a web-based bioinformatics platform enabling biology teams to analyse, store, curate, and share genomics data at scale. Built around Nextflow pipeline integration, Flow provides a user-friendly interface for RNA-seq and other omics workflows, linking…

Electrochemical biosensors for biopharmaceutical biosafety and diagnostics

Aureum Diagnostics is a biotechnology company developing electrochemical biosensor platforms for rapid detection of biological and chemical targets. Its technology combines portable readers with disposable test strips and cartridges to measure analytes including nucleic acids and proteins. The company serves…

Global influenza vaccine leader with major UK manufacturing in Liverpool

CSL Seqirus is one of the world's largest influenza vaccine companies, operating the only injectable influenza vaccine manufacturing facility in the UK at Speke, Liverpool. The site employs more than 650 people and produces egg-based and cell culture-derived influenza vaccines for seasonal and pandemic use, with surge…

Clinical skin microbiome testing and multi-omic ingredient analysis platform

Sequential Skin is a biotechnology company providing non-invasive clinical microbiome testing and multi-omic analysis services to the personal care and pharmaceutical industries. Using patch-based sampling and next-generation sequencing, the company quantifies how ingredients and formulations affect the skin…

Preclinical CRO for receptor pharmacology and occupancy studies

Gifford Bioscience is a contract research organisation providing receptor pharmacology and occupancy services for preclinical and discovery stage drug development. The company conducts radioligand binding assays, functional GPCR assays, receptor occupancy studies, autoradiography, and surface plasmon resonance using…

AI-guided personalised mRNA cancer vaccine development

Genevation is a biotechnology company developing personalised mRNA cancer vaccines using AI-assisted tumour neoantigen identification. Its platform analyses tumour sequencing data to select patient-specific targets and combines computational vaccine design with cell-free RNA manufacturing. The company reports…

Bioelectronic plant sensors for agricultural stress monitoring

Mycovolt Technologies is an agritech company developing bioelectronic sensors that measure electrical signals within living plants. Its biocompatible, non-invasive interfaces monitor plant electrophysiology to detect stress responses and provide crop health information. The technology is being developed for…

Oncolytic virus immunotherapies engineered to destroy solid tumours

Bioarchitech is a preclinical-stage biotechnology company developing oncolytic virus-based immunotherapies for the treatment of common solid tumours. The company engineers vaccinia virus to encode antibody-like immunotherapy molecules within the viral genome, enabling localised delivery of immune-activating payloads…

Infectious disease drug development and partnering organisation

Infex Therapeutics is a clinical-stage drug development company focused on antimicrobial resistance and pandemic-priority infectious diseases, based at Alderley Park. Founded as The AMR Centre in 2016, the company acquires and co-develops novel therapeutics through in-licensing and risk-sharing partnerships with…

Off-the-shelf cancer immunotherapies targeting solid tumours

Scancell is a clinical-stage biotech developing active immunotherapies and antibody-based therapeutics for cancer. Its pipeline spans DNA cancer vaccines, peptide immunotherapies and tumour-specific monoclonal antibodies targeting glycans expressed on cancer cells. Lead programmes iSCIB1+ and Modi-1 are in Phase 2…

Preclinical small-molecule therapeutics targeting a novel pathway in chronic pain

Sevenless Therapeutics is a preclinical biotechnology company developing small-molecule medicines for people with chronic pain that responds poorly to existing treatments. The company has identified a new target in pain signalling using computational and mathematical modelling approaches and is designing small…

High-sensitivity lateral flow diagnostics for point-of-care testing

SwiftDx is a Cambridge-based diagnostics company developing a next generation of high-sensitivity lateral flow assays using proprietary eAMP (enhanced Amplification) and DNA detection technologies. Its platform enables detection of targets undetectable by conventional lateral flow tests, without requiring specialist…

Cell therapy for vascular regeneration in ischaemic and wound healing conditions

VascVersa is a Belfast-based regenerative medicine company developing cell therapies for vascular regeneration and repair. The company's technology uses vasoreparative cells to stimulate new blood vessel formation and restore blood supply in conditions characterised by impaired circulation. The lead programme targets…

In vitro pharmacology CRO for preclinical drug discovery

Excellerate Bioscience is a contract research organisation specialising in molecular and cellular pharmacology for preclinical drug discovery. The company provides in vitro assay development, biochemical and cell-based screening, target validation, and compound profiling services to pharmaceutical companies,…